Aage Drivsholm

427 total citations
23 papers, 357 citations indexed

About

Aage Drivsholm is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Aage Drivsholm has authored 23 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Aage Drivsholm's work include Multiple Myeloma Research and Treatments (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (3 papers). Aage Drivsholm is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (3 papers). Aage Drivsholm collaborates with scholars based in Denmark and Norway. Aage Drivsholm's co-authors include Preben Philip, Mogens Krogh Jensen, Niels Ebbe Hansen, Sven-Åge Killmann, Henrik Birgens, J. B. Hertz, Hans Jørgen Nielsen, F. Espersen, Sven‐Aage Killmann and Henrik Nielsen and has published in prestigious journals such as Cancer Immunology Immunotherapy, American Journal of Hematology and Apmis.

In The Last Decade

Aage Drivsholm

22 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aage Drivsholm Denmark 12 257 111 101 77 65 23 357
K Hirashima Japan 12 295 1.1× 99 0.9× 99 1.0× 134 1.7× 78 1.2× 44 465
Y Yoshida Japan 12 309 1.2× 134 1.2× 113 1.1× 66 0.9× 157 2.4× 45 515
Rita Michalevicz Israel 14 177 0.7× 97 0.9× 134 1.3× 75 1.0× 163 2.5× 31 422
Henriëtte M. Goselink Netherlands 10 272 1.1× 80 0.7× 83 0.8× 111 1.4× 207 3.2× 18 464
JH Bourhis United States 8 437 1.7× 151 1.4× 77 0.8× 136 1.8× 119 1.8× 10 507
M Okabe Japan 11 251 1.0× 119 1.1× 166 1.6× 93 1.2× 58 0.9× 33 425
LD Petz United States 8 403 1.6× 43 0.4× 112 1.1× 40 0.5× 106 1.6× 11 480
S. K. China 11 176 0.7× 85 0.8× 61 0.6× 46 0.6× 46 0.7× 23 337
E A Harden United States 7 148 0.6× 107 1.0× 44 0.4× 87 1.1× 111 1.7× 8 375
S. Donald Zaentz United States 7 119 0.5× 54 0.5× 116 1.1× 65 0.8× 104 1.6× 8 332

Countries citing papers authored by Aage Drivsholm

Since Specialization
Citations

This map shows the geographic impact of Aage Drivsholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aage Drivsholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aage Drivsholm more than expected).

Fields of papers citing papers by Aage Drivsholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aage Drivsholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aage Drivsholm. The network helps show where Aage Drivsholm may publish in the future.

Co-authorship network of co-authors of Aage Drivsholm

This figure shows the co-authorship network connecting the top 25 collaborators of Aage Drivsholm. A scholar is included among the top collaborators of Aage Drivsholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aage Drivsholm. Aage Drivsholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keldsen, Nina, Ole Weis Bjerrum, Inger Marie S. Dahl, et al.. (1993). Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study. European Journal Of Haematology. 51(2). 80–85. 3 indexed citations
2.
Nielsen, Henrik, Hans Jørgen Nielsen, N. Tvede, et al.. (1991). Immune dysfunction in multiple myeloma. Reduced natural killer cell activity and increased levels of soluble interleukin‐2 receptors. Apmis. 99(1-6). 340–346. 26 indexed citations
3.
Nielsen, Henrik, Henrik Nielsen, Inge Clemmensen, et al.. (1990). Decreased tetranectin in multiple myeloma. American Journal of Hematology. 33(2). 142–144. 16 indexed citations
4.
Nielsen, Hans Jørgen, Henrik Nielsen, F Moesgaard, et al.. (1990). The effect of ranitidine on cellular immunity in patients with multiple myeloma. Cancer Immunology Immunotherapy. 32(3). 201–205. 5 indexed citations
5.
Bjerrum, Ole Weis, Hans Carl Hasselbalch, Aage Drivsholm, & Nis I. Nissen. (1986). Non‐Hodgkin malignant lymphomas and Hodgkin's disease in first‐degree relatives. Scandinavian Journal of Haematology. 36(4). 398–401. 10 indexed citations
6.
Drivsholm, Aage, Ida Maria Lisse, & Preben Philip. (1985). Development of acute nonlymphocytic leukaemia (ANLL) in myelomatosis. Scandinavian Journal of Haematology. 35(1). 35–37. 4 indexed citations
7.
Clausen, Nielsaage Tøffner, et al.. (1985). Phase III study of intermittent 5‐drug regimen (VBCMP) versus intermittent 3‐drug regimen (VMP) versus intermittent melphalan and prednisone (MP) in myelomatosis. Scandinavian Journal of Haematology. 35(5). 518–524. 16 indexed citations
8.
Espersen, F., Henrik Birgens, J. B. Hertz, & Aage Drivsholm. (1984). Current Patterns of Bacterial Infection in Myelomatosis. Archives of Physiology and Biochemistry. 16(2). 169–173. 3 indexed citations
9.
Espersen, F., Henrik Birgens, J. B. Hertz, & Aage Drivsholm. (1984). Current Patterns of Bacterial Infection in Myelomatosis. Scandinavian Journal of Infectious Diseases. 16(2). 169–173. 21 indexed citations
10.
Birgens, Henrik, F. Espersen, J. B. Hertz, Freddy Karup Pedersen, & Aage Drivsholm. (1983). Antibody Response to Pneumococcal Vaccination in Patients with Myelomatosis. Scandinavian Journal of Haematology. 30(4). 324–330. 20 indexed citations
11.
Drivsholm, Aage, et al.. (1982). Renal plasma clearance: A valuable marker in myelomatosis. Annals of Hematology. 45(1). 1–11. 3 indexed citations
12.
Philip, Preben, Mogens Krogh Jensen, Sven-Åge Killmann, Aage Drivsholm, & Niels Ebbe Hansen. (1978). Chromosomal banding patterns in 88 cases of acute nonlymphocytic leukemia. Leukemia Research. 2(3). 201–212. 71 indexed citations
13.
Drivsholm, Aage, et al.. (1978). Interrelationships between Vitamin B12 and Folic Acid in Myelomatosis: Cobalamin Coenzyme and Tetrahydrofolic Acid Function. Scandinavian Journal of Haematology. 20(4). 360–370. 8 indexed citations
14.
Drivsholm, Aage, et al.. (1978). Interrelationships between Blood Volume, Venous Haematocrit and Renal Failure in Myelomatosis. Scandinavian Journal of Haematology. 20(5). 461–466. 7 indexed citations
15.
Thorling, Eivind B., et al.. (1977). Serum Erythropoietin in Myelomatosis. Scandinavian Journal of Haematology. 19(1). 106–110. 14 indexed citations
16.
Drivsholm, Aage, et al.. (1977). Vitamin B12 Metabolism in Myelomatosis. Scandinavian Journal of Haematology. 18(5). 395–402. 11 indexed citations
17.
Drivsholm, Aage. (1964). Turnover Rate of Paraproteins in Myelomatosis. Acta Medica Scandinavica. 176(3). 257–267. 8 indexed citations
18.
Drivsholm, Aage. (1964). Myelomatosis. Acta Medica Scandinavica. 176(4). 509–524. 28 indexed citations
19.
Drivsholm, Aage. (1964). Cytometric Studies of Myeloma Cells. Acta Medica Scandinavica. 176(1). 79–89. 1 indexed citations
20.
Drivsholm, Aage. (1961). Turnover Rate of Myeloma Proteins in Serum and Urine Determined after Intravital Labelling with Glycine—1—C—14. Acta Medica Scandinavica. 169(5). 503–507. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Hirashima Breakdown of academic impact, for papers by Y Yoshida Breakdown of academic impact, for papers by Rita Michalevicz Breakdown of academic impact, for papers by Henriëtte M. Goselink Breakdown of academic impact, for papers by JH Bourhis Breakdown of academic impact, for papers by M Okabe Breakdown of academic impact, for papers by LD Petz Breakdown of academic impact, for papers by S. K. Breakdown of academic impact, for papers by E A Harden Breakdown of academic impact, for papers by S. Donald Zaentz
Rankless by CCL
2026